Sylvia G. Kachalsky

Molecular Detection, Inc. develops and commercializes molecular diagnostic tests to detect infectious diseases. It offers Detect-Ready methicillin-resistant Staphylococcus aureus (MRSA) panel that allows for the detection of MRSA. The company was founded by Aryeh L. Gassel in 2007 and is headquartered in Wayne, PA.

Part of Atonomics A/S, Azign Bioscience AS is a biotechnology company based in Copenhagen, Denmark. The Danish company provides biotechnology services. Azign Bioscience was acquired by Atonomics A/S from NTG Nordic Transport Group A/S on June 30, 2004.

Part of Merck KGaA, Interpharm Laboratories Ltd. is an Israeli company that develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases. The company is based in Rehovot, Israel. The company was founded by Israel Makov.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

Agazyme Ltd. operates was a biotech company. It was engages in the research and development of alkaline alpha galactosides for food, beverage, and cosmetic industries. The company was founded in 2007 and is headquartered in Tel Aviv, Israel.